SCHEMBL16615489

SCHEMBL16615489

CCCCNS(=O)(=O)c1ccc(NC(=O)C(CC)c2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.70
ALDH1A1 P00352 5/20 0.70
HTT P42858 3/20 0.70
KMT2A Q03164 3/20 0.70
MAPT P10636 2/20 0.70
POLB P06746 1/20 0.70
GPR55 Q9Y2T6 1/20 0.70
CRHBP P24387 2/20 0.58
CRHR2 Q13324 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.55
HDAC3 O15379 3/20 0.55
HDAC4 P56524 3/20 0.55
HDAC1 Q13547 3/20 0.55
HDAC7 Q8WUI4 3/20 0.55
HDAC2 Q92769 3/20 0.55
HDAC10 Q969S8 3/20 0.55
HDAC11 Q96DB2 3/20 0.55
HDAC8 Q9BY41 3/20 0.55
HDAC6 Q9UBN7 3/20 0.55
HDAC9 Q9UKV0 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615822 0.88 ALDH1A1 (0.66) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL16615516 0.83 SMN1; SMN2 (0.65) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL16615530 0.82 ALDH1A1 (0.70) LMNAALDH1A1HTTMAPTPOLB
SCHEMBL16615850 0.82 SCN3A (0.65) LMNAALDH1A1HTTPOLBCRHBP
SCHEMBL19262185 0.81 LMNA (0.63) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL9138268 0.80 ALDH1A1 (0.68) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL16615514 0.79 L3MBTL1 (0.62) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL16615791 0.78 ALDH1A1 (0.65) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL7752354 0.78 ALDH1A1 (0.82) LMNAALDH1A1HTTKMT2AMAPT
SCHEMBL19074542 0.78 ALDH1A1 (0.82) LMNAALDH1A1HTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF Université de Montréal (CA) 2016-07-28 US disclosed
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF Université de Montréal (CA) 2016-07-28 US disclosed
WO-2015042685-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF VALORISATION-RECHERCHE (CA) 2015-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF FBL, HNRNPA1, HNRNPUL1 LMNA 705/4885ALDH1A1 4383/4885HTT 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.